AT03-65 is the first program utilizing AxcynDOT™,a proprietary payload with a differentiated mechanism of action,to enter clinical development
NEW HAVEN,Conn.,Jan. 13,2025-- XingImaging,a MITRO company,a leader in advanced research imaging and radiopharmaceutical services,is excited to announce the opening of its new state-of-the art resear
MELBOURNE,Australiaand INDIANAPOLIS,Jan. 13,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today provides an update on its commercial and operational performance for th
HUZHOU,China,Jan. 13,2025-- Recently,Tianneng have released a brand-new global brand slogan -"Energy For All".
DUBLIN and STAMFORD,Conn.,Jan. 13,2025--AIP Capital,an alternative investment manager focused on opportunities in asset-based finance today announced that it has expanded its leadership team with sev
SHANGHAI,Jan. 13,2025-- As the world\'s population grows and industrialization accelerates,the conflict between energy and the environment is intensifying. The search for a balance between energy sup
